NC
KERX

Northpointe Capital’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Northpointe Capital’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-426,849
Closed -$5.43M – 254
2015
Q1 		$5.43M Sell
426,849
-87,596
-17% -$1.13M 0.59% 53
2014
Q4 		$7.28M Buy
514,445
+49,650
+11% +$769K 0.87% 30
2014
Q3 		$6.39M Sell
464,795
-427,216
-48% -$6.54M 0.68% 60
2014
Q2 		$13.7M Buy
892,011
+14,136
+2% +$200K 1.32% 7
2014
Q1 		$15M Sell
877,875
-411,836
-32% -$6.21M 1.52% 9
2013
Q4 		$16.7M Buy
1,289,711
+228,285
+22% +$2.73M 1.47% 14
2013
Q3 		$10.7M Sell
1,061,426
-43,840
-4% -$390K 1.26% 21
2013
Q2 		$8.26M Buy
+1,105,266
New +$8.64M 0.95% 32

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return